Literature DB >> 10973302

Is the development of a new tuberculosis vaccine possible?

S H Kaufmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10973302     DOI： 10.1038/79631

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  63 in total

1.  Clinical practice in the new era. A fusion of molecular biology and classical medicine is transforming the way we look at and treat diseases.

Authors:  A G Papavassiliou
Journal:  EMBO Rep       Date:  2001-02       Impact factor: 8.807

2.  gp96-peptide vaccination of mice against intracellular bacteria.

Authors:  U Zügel; A M Sponaas; J Neckermann; B Schoel; S H Kaufmann
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 3.  The many faces of host responses to tuberculosis.

Authors:  H L Collins; S H Kaufmann
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

4.  Magnetic resonance imaging of pulmonary lesions in guinea pigs infected with Mycobacterium tuberculosis.

Authors:  Susan L Kraft; Deanna Dailey; Matthew Kovach; Karen L Stasiak; Jamie Bennett; Christine T McFarland; David N McMurray; Angelo A Izzo; Ian M Orme; Randall J Basaraba
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents.

Authors:  Chelsea Carpenter; John Sidney; Ravi Kolla; Kaustuv Nayak; Helena Tomiyama; Claudia Tomiyama; Oscar A Padilla; Virginie Rozot; Syed F Ahamed; Carlos Ponte; Valeria Rolla; Paulo R Antas; Anmol Chandele; John Kenneth; Seetha Laxmi; Edward Makgotlho; Valentina Vanini; Giuseppe Ippolito; Alexandra S Kazanova; Alexander V Panteleev; Willem Hanekom; Harriet Mayanja-Kizza; David Lewinsohn; Mayuko Saito; M Juliana McElrath; W Henry Boom; Delia Goletti; Robert Gilman; Irina V Lyadova; Thomas J Scriba; Esper G Kallas; Kaja Murali-Krishna; Alessandro Sette; Cecilia S Lindestam Arlehamn
Journal:  Tuberculosis (Edinb)       Date:  2015-08-01       Impact factor: 3.131

6.  Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.

Authors:  Hilary Clay; Hannah E Volkman; Lalita Ramakrishnan
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

Review 7.  Development of new vaccines and drugs for TB: limitations and potential strategic errors.

Authors:  Ian M Orme
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

8.  Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.

Authors:  Lihao Chen; Jun Wang; Anna Zganiacz; Zhou Xing
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 9.  [Immunology of tuberculosis: impact on the development of novel vaccines].

Authors:  T Ulrichs; S H E Kaufmann
Journal:  Internist (Berl)       Date:  2003-11       Impact factor: 0.743

10.  Voltage gated calcium channels negatively regulate protective immunity to Mycobacterium tuberculosis.

Authors:  Shashank Gupta; Nasir Salam; Varsha Srivastava; Rupak Singla; Digamber Behera; Khalid U Khayyam; Reshma Korde; Pawan Malhotra; Rajiv Saxena; Krishnamurthy Natarajan
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.